Sales rise 19.09% to Rs 738.98 crore
Net profit of Glaxosmithkline Pharma rose 27.46% to Rs 128.67 crore in the quarter ended September 2014 as against Rs 100.95 crore during the previous quarter ended September 2013. Sales rose 19.09% to Rs 738.98 crore in the quarter ended September 2014 as against Rs 620.54 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales738.98620.54 19 OPM %22.3218.38 -PBDT200.64153.43 31 PBT195.15148.47 31 NP128.67100.95 27Powered by Capital Market - Live News